Steminent Biotherapeutics, Inc. develops novel cellular therapeutics and engages in the research and development of new stem cell drugs. Its products include Stemchymal, Stemchymal Therapeutic Advantages and Stemchymal Product Safety. The company was founded on December 18, 2007 and is headquartered in Taipei, Taiwan.